furosemide has been researched along with Myeloproliferative Disorders in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 7.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 3.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "We report a woman with myelofibrosis and myeloid metaplasia who presented with dyspnea and massive, painful splenomegaly." | 1.35 | [Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia]. ( Anouti, S; Haddad, F; Jammal, M; Kettaneh, A; Maalouly, G; Nemnoum, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haddad, F | 1 |
| Anouti, S | 1 |
| Maalouly, G | 1 |
| Jammal, M | 1 |
| Nemnoum, R | 1 |
| Kettaneh, A | 1 |
| Famularo, G | 1 |
| De Simone, C | 1 |
| Becher, R | 1 |
| Löhren, D | 1 |
| Firusian, N | 1 |
1 review available for furosemide and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Acute hypercalcemia as an oncological emergency. Pathogenesis, clinical aspects, therapy].
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Electrocardiography; Female; Fluid Therapy; | 1980 |
2 other studies available for furosemide and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].
Topics: Anticoagulants; Cardiac Catheterization; Diagnosis, Differential; Diuretics; Drug Therapy, Combinati | 2009 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruption | 2002 |